Similar Items: Evaluating the value of neoadjuvant radiotherapy in patients with breast cancer
- Pathologic and radiologic response to neoadjuvant therapy in advanced differentiated thyroid cancer
- Toxicity outcomes of concurrent radiotherapy with adjuvant capecitabine in triple-negative breast cancer (TROD 06-24)
- Clinicopathological discordance and survival outcomes in 154 breast cancer patients with pulmonary metastasis in a real-world setting
- Association between serum chemerin and breast cancer mediated by lipid metabolism
- Integrating multi-omics and clinical management in breast cancer: a comprehensive review
- Exploring the functional role of XIST in breast cancer from mechanisms to clinical implications